Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,735
Closed -$277K 110
2021
Q1
$277K Sell
3,735
-550
-13% -$41.8K 0.13% 88
2020
Q4
$312K Hold
4,285
0.14% 87
2020
Q3
$284K Buy
4,285
+15
+0.4% +$949 0.14% 81
2020
Q2
$243K Buy
+4,270
New +$210K 0.12% 93
2020
Q1
Sell
-11,160
Closed -$582K 90
2019
Q4
$582K Buy
+11,160
New +$556K 0.3% 65
2013
Q3
Sell
-304,580
Closed -$5.88M 106
2013
Q2
$5.88M Buy
+304,580
New +$6.36M 1.57% 31

Other funds holding HOLX

Chase Investment Counsel's HOLX Position: Q2 2021 in Review

Chase Investment Counsel sold out of Hologic (HOLX) in Q2 2021, closing a stake of 3,735 shares — an estimated $277K sold.

Chase Investment Counsel first reported a position in HOLX in Q2 2013 and held it in 6 quarters. The position peaked at $5.88M in Q2 2013. 625 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

  • Chase Investment Counsel reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
  • Chase Investment Counsel sold 3,735 Hologic shares in Q2 2021, an estimated $277K.
  • Chase Investment Counsel first reported a position in Hologic in Q2 2013 and held it in 6 quarters.
  • Chase Investment Counsel's Hologic position peaked at $5.88M in Q2 2013.
  • 625 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Chase Investment Counsel's 13F filing for Q2 2021, filed 29 Jul 2021.